Wire by Fusion42
Fusion42 Scout Raise
The Debrief & Outliers
Regulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers
Benchmarks
Benchmarks HomeBy News TypeBy RegionBy Sector
AI WeeklyAbout

Switch product

Fusion42RaiseScoutWire

The Debrief & Outliers

All editionsRegulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers

Database & benchmarks

Benchmarks HomeBy News TypeBy RegionBy SectorStories

Account

Sign in
← Back

Wire · opportunities

RGHS diagnostic claims fall 35 per cent after tighter CT, MRI approval rules

22 August 2026 · By · Wire by Fusion42

Published

22 August 2026

Topic

opportunities

◆ Sectors

Medtech

◆ Geography

India

◆ Source

Read at medicaldialogues.in →

◆ Verified

Fusion42 · 22 August 2026 · Fusion42 review

The RGHS diagnostic claims dropped by 35% following the implementation of stricter approval rules for CT and MRI scans. This regulatory tightening impacts diagnostic service providers under the RGHS scheme in India by reducing claim volumes.

This Wire brief sits within Fusion42's coverage of Medtech.

◆ ◆ The Wire takeaway

Diagnostic medtech founders in India need to adapt fast as CT and MRI approvals now require more scrutiny, sharply cutting claim volumes. Your growth plans reliant on volume-based claims should be reassessed immediately.

◆ Coverage

1 source · 22 Aug 2026

◆ Related on Wire

◆ Topics

Medtechhealthcareregulatory-changediagnosticsimagingIndia